NCT05802693 2023-08-25
A Study to Evaluate the Safety, Tolerance and Initial Efficacy of EGFRvIII CAR-T on Glioblastoma
Beijing Tsinghua Chang Gung Hospital
Phase EARLY_PHASE1 Unknown
Beijing Tsinghua Chang Gung Hospital
The Second Hospital of Hebei Medical University
Hebei Senlang Biotechnology Inc., Ltd.
Huashan Hospital
Xiangya Hospital of Central South University
Xijing Hospital
University of Virginia
Beijing Tiantan Hospital